Molecular profiling of hepatocellular carcinomas by cDNA microarray.

Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. Conventional diagnosis and treatment of this malignancy have been dismal and should be complemented by novel tools. The development and progress of HCC are believed to be caused by the accumulation of genetic changes resulting in altered expression of thousands of cancer-related genes, which can be measured by globe genetic analysis. Gene expression profiling of HCC has been employed to elucidate hepatocarcinogenesis and disclose molecular mechanisms underlying complex clinical features. Identifying phenotype-associated genes/profiles has impacts on current diagnosis and management strategy of HCC. In spite of some pitfalls of this technology and challenges in improving the research process, scrutinous validation of profiling data of HCC combined with other approaches will eventually benefit the patients.

[1]  R. Zeillinger,et al.  Identification of Genes Associated with the Invasive Status of Human Mammary Carcinoma Cell Lines by Transcriptional Profiling , 2003, Tumor Biology.

[2]  M. Yuen,et al.  Screening for hepatocellular carcinoma: survival benefit and cost-effectiveness. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  R. Jordan,et al.  Molecular viral oncology of hepatocellular carcinoma , 2003, Oncogene.

[4]  D. Welch,et al.  Metastasis suppressor pathways--an evolving paradigm. , 2003, Cancer letters.

[5]  H. Hsu,et al.  Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma , 2003, Cancer.

[6]  Yusuke Nakamura,et al.  Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. , 2003, Biochemical and biophysical research communications.

[7]  Lajos Pusztai,et al.  Clinical application of cDNA microarrays in oncology. , 2003, The oncologist.

[8]  Y. Yen,et al.  Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. , 2003, The American journal of pathology.

[9]  Q. Ye,et al.  Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis , 2003, Journal of Cancer Research and Clinical Oncology.

[10]  D. Arango,et al.  Microarray analysis in the clinical management of cancer. , 2003, Hematology/oncology clinics of North America.

[11]  X. Wang,et al.  Predicting hepatitis B virus–positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning , 2003, Nature Medicine.

[12]  S. Fan,et al.  Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis , 2003, The Journal of pathology.

[13]  Jin Woo Kim,et al.  Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases? , 2003, Carcinogenesis.

[14]  Sorin Draghici,et al.  Gene expression databases and data mining. , 2003, BioTechniques.

[15]  P. Lazo,et al.  Apoptosis protection and survival signal by the CD53 tetraspanin antigen , 2003, Oncogene.

[16]  Y. N. Park,et al.  Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries. , 2003, Japanese journal of infectious diseases.

[17]  Edison T Liu,et al.  Classification of cancers by expression profiling. , 2003, Current opinion in genetics & development.

[18]  T. Yeatman,et al.  The Future of Clinical Cancer Management: One Tumor, One Chip , 2003, The American surgeon.

[19]  S. Hirohashi,et al.  Expression profiling in multistage hepatocarcinogenesis: Identification of HSP70 as a molecular marker of early hepatocellular carcinoma , 2003, Hepatology.

[20]  Stephen M. Hewitt,et al.  Post-analysis follow-up and validation of microarray experiments , 2002, Nature Genetics.

[21]  Rui Li,et al.  Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Yan Li,et al.  [Gene expression profile of human hepatocellular carcinoma cell lines with different metastatic potentials]. , 2002, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[23]  Rui Li,et al.  Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines , 2002, Oncogene.

[24]  J. Klempnauer,et al.  Comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) in the diagnosis of hepatocellular carcinoma. , 2002, Journal of hepato-biliary-pancreatic surgery.

[25]  Xin Chen,et al.  Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. , 2002, Cancer research.

[26]  P. F. Macgregor,et al.  Application of microarrays to the analysis of gene expression in cancer. , 2002, Clinical chemistry.

[27]  B. Bodey.  Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy , 2002, Expert opinion on biological therapy.

[28]  S. Thorgeirsson,et al.  Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.

[29]  David I. Smith,et al.  Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas , 2002, Oncogene.

[30]  G. Leikauf,et al.  Microarrays as cancer keys: an array of possibilities. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  N. Iizuka,et al.  Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. , 2002, Cancer research.

[32]  D. Botstein,et al.  Gene expression patterns in human liver cancers. , 2002, Molecular biology of the cell.

[33]  O. Delpuech,et al.  Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma , 2002, Oncogene.

[34]  A. Tannapfel,et al.  Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis , 2002, Virchows Archiv.

[35]  S. Hirohashi,et al.  Overexpression of osteopontin in hepatocellular carcinoma , 2002, Pathology international.

[36]  G. Fu,et al.  Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Welsh,et al.  Molecular classification of human carcinomas by use of gene expression signatures. , 2001, Cancer research.

[38]  O. Nakashima,et al.  Recurrence of hepatocellular carcinoma: multicentric occurrence or intrahepatic metastasis? A viewpoint in terms of pathology. , 2001, Journal of hepato-biliary-pancreatic surgery.

[39]  Z. Tang,et al.  Hepatocellular carcinoma--cause, treatment and metastasis. , 2001, World journal of gastroenterology.

[40]  T. Utsunomiya,et al.  Characteristics of Multicentric Hepatocellular Carcinomas: Comparison with Intrahepatic Metastasis , 2001, World Journal of Surgery.

[41]  Jack A. Taylor,et al.  Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[42]  T. Tsunoda,et al.  Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. , 2001, Cancer research.

[43]  P. Johnson,et al.  The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. , 2001, Clinics in liver disease.

[44]  W. Yasui,et al.  “Gene Diagnosis‐Introduction of New Technology”: The Tenth International Symposium of the Hiroshima Cancer Seminar, October 2000 , 2001, Japanese journal of cancer research : Gann.

[45]  J. Klempnauer,et al.  Differentiation of multicentric origin from intra‐organ metastatic spread of hepatocellular carcinomas by comparative genomic hybridization , 2000, The Journal of pathology.

[46]  S. Kaneko,et al.  Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning. , 2000, Journal of hepatology.

[47]  M. Colombo.  Epidemiology of hepatocellular carcinoma. , 1995, The Italian journal of gastroenterology.

[48]  G. Dusheiko,et al.  Management of hepatocellular carcinoma. , 1992, Journal of hepatology.

[49]  D. Welch,et al.  Breast cancer metastasis suppressor 1: Update , 2004, Clinical & Experimental Metastasis.

[50]  Hermann-Josef Gröne,et al.  Laser-controlled microdissection of tissues opens a window of new opportunities. , 2003, Pathology, research and practice.

[51]  P. Steeg.  Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.

[52]  G. Chau,et al.  Spectrum and significance of microscopic vascular invasion in hepatocellular carcinoma. , 2003, Surgical oncology clinics of North America.

[53]  S. Fan,et al.  Evaluation of the new AJCC/UICC staging system for hepatocellular carcinoma after hepatic resection in Chinese patients. , 2003, Surgical oncology clinics of North America.

[54]  J. Macoska.  The Progressing Clinical Utility of DNA Microarrays , 2002, CA: a cancer journal for clinicians.

[55]  S. Ye,et al.  Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray , 2002, Journal of Cancer Research and Clinical Oncology.

[56]  Yao-Tseng Chen,et al.  Expression of cancer-testis genes in human hepatocellular carcinomas. , 2002, Cancer immunity.

[57]  M. Lanotte,et al.  Exploring (novel) gene expression during retinoid-induced maturation and cell death of acute promyelocytic leukemia. , 2001, Seminars in hematology.

[58]  M. Diehn.  Large-scale identification of secreted and membrane-associated gene products using DNA microarrays , 1999, Nature Genetics.